tiprankstipranks
Trending News
More News >
Neurosense Therapeutics Ltd. (NRSN)
:NRSN
US Market
Advertisement

Neurosense Therapeutics Ltd. (NRSN) Income Statement

Compare
156 Followers

Neurosense Therapeutics Ltd. Income Statement

Last quarter (Q3 2024), Neurosense Therapeutics Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Neurosense Therapeutics Ltd.'s net income was $-2.15M. See Neurosense Therapeutics Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -22.00K$ -97.00K$ -89.00K$ -3.00K$ -3.00K
Operating Expenses
$ 9.88M$ 12.05M$ 13.55M$ 5.59M$ 2.89M
Depreciation and Amortization
$ 22.00K$ 97.00K$ 89.00K$ 3.00K$ 3.00K
EBITDA
$ -9.88M$ -9.64M$ -13.38M$ -2.88M$ -2.83M
Operating Income
$ -9.90M$ -12.05M$ -13.55M$ -5.59M$ -2.89M
Other Income/Expenses
$ -308.00K$ 769.00K$ 1.21M$ 1.55M$ 60.00K
Pretax Income
$ -10.21M$ -11.28M$ -12.34M$ -4.04M$ -2.83M
Net Income
$ -10.21M$ -10.11M$ -10.49M$ -2.50M$ -2.83M
Per Share Metrics
Basic EPS
$ -0.55$ -0.83$ -0.97$ -0.23$ -1.46
Diluted EPS
$ -0.55$ -0.83$ -0.97$ -0.23$ -1.46
Weighted Average Shares Outstanding
18.60M 13.64M 11.51M 10.86M 5.52M
Weighted Average Shares Outstanding (Diluted)
18.60M 13.64M 11.51M 10.86M 5.52M
Currency in USD

Neurosense Therapeutics Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis